高级搜索
青春期鼻咽癌的放射治疗试析[J]. 肿瘤防治研究, 1999, 26(4): 303-304.
引用本文: 青春期鼻咽癌的放射治疗试析[J]. 肿瘤防治研究, 1999, 26(4): 303-304.
Analysis of 102 Nasophyrynageal Carcinoma(NPC) in the Age of Puberty[J]. Cancer Research on Prevention and Treatment, 1999, 26(4): 303-304.
Citation: Analysis of 102 Nasophyrynageal Carcinoma(NPC) in the Age of Puberty[J]. Cancer Research on Prevention and Treatment, 1999, 26(4): 303-304.

青春期鼻咽癌的放射治疗试析

Analysis of 102 Nasophyrynageal Carcinoma(NPC) in the Age of Puberty

  • 摘要: 目的: 本文回顾性分析青春期这一特殊年龄段鼻咽癌患者的特征及治疗效果, 并涉及远期并发症。方法: 1975年7月至1992年12月, 我院收治102例青春期鼻咽癌, Ⅲ 、Ⅳ期占84.3 %(86/102), 全部接受放疗, 其中6例N3患者接受化疗。结果: 全组局部控制率为75.9 %(78/102), 1 、3 、5 年生存率分别为89.9 %(86/102), 60.7 %(62/102), 58.6 %(60/102), Ⅲ 、Ⅳa 期5年生存率为52.4 %(38/86)。6例N3患者配合化疗3例存活5年以上。远期并发症包括不育和发育迟缓和继发性闭经。远处转移是主要死亡原因。 结论: 尽管青春期鼻咽癌患者初诊时多为局部晚期, 但经根治性放疗后获得良好疗效。联用化疗可能增加疗效。由于许多患者获长期生存, 远期并发症影响生存质量的问题就显得格外突出。

     

    Abstract: Objective: To analysize retrospectively the characteristics of the teenagers with NPC. Methods: 102 teenagers with NPC received external irradiation, among them, 6 cases with N3 diseases was treaed with chemotherapy simutaneously. The tumor dose of primary site was 38Gy-82Gy with an average dose of 66Gy. The number of patients with stage Ⅲ-Ⅳ was 86 which instituted 85% of the whole groupe. Reaults: After a minimum follow-up of 5 years, the overall 5 years survival rate was 58.6%. Administration of RT +CT to 6 cases with N3 disease survived 3 cases. The main cause of deaths was remote metastases. Sterility and secondary amenorrhea was found in this group. Conclusion: (1) Applications of chemotherpy may improve the suvives of patients with N3 disease. (2) The protection of hypophysis of the youngs against irradiation should be emphasized.

     

/

返回文章
返回